Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Medicina Clinica
|
October 4, 2025
Common variable immunodeficiency
Xavier Solanich, Arnau Antolí, Laia Alsina
Journal of Clinical Medicine
|
March 3, 2021
Clinical Significance of Indeterminate QuantiFERON-TB Gold Plus Assay Results in Hospitalized COVID-19 Patients with Severe Hyperinflammatory Syndrome
Xavier Solanich, Miguel Fernández-Huerta, Celeste Basaez, et al.
European Journal of Case Reports in Internal Medicine
|
June 7, 2024
Severe Gastrointestinal Cytomegalovirus Infection in a Patient Diagnosed with Late Onset Combined Immunodeficiency
Georgina Sauqué Pintos, Arnau Antolí Gil, Gemma Rocamora Blanch, et al.
Frontiers in Immunology
|
April 1, 2025
Non-neutralizing anti-type I interferon autoantibodies could increase thrombotic risk in critical COVID-19 patients
Mario Framil, Lydia García-Serrano, Francisco Morandeira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 7, 2023
Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial
Pierre Malchair, Jordi Giol, Vanesa García, et al.
Journal of Clinical Immunology
|
May 27, 2025
From Rare to Common: Genetic Insights into TLR7 Variants in a Multicentric Spanish Study on COVID-19 Severity
Arnau Antolí, Gardenia Vargas-Parra, Angels Sierra-Fortuny, et al.
Frontiers in Immunology
|
May 16, 2022
Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy
Arnau Antolí, Gemma Rocamora-Blanch, Mario Framil, et al.
Clinical Immunology (Orlando, Fla.)
|
April 4, 2025
Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patients
Arnau Antolí, José Luis Gómez-Vázquez, Angels Sierra-Fortuny, et al.
Frontiers in Medicine
|
July 1, 2021
Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial
Xavier Solanich, Arnau Antolí, Gemma Rocamora-Blanch, et al.
Frontiers in Immunology
|
August 9, 2021
Genetic Screening for <i>TLR7</i> Variants in Young and Previously Healthy Men With Severe COVID-19
Xavier Solanich, Gardenia Vargas-Parra, Caspar I van der Made, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Medicina Clinica
|
October 4, 2025
Common variable immunodeficiency
Xavier Solanich, Arnau Antolí, Laia Alsina
Journal of Clinical Medicine
|
March 3, 2021
Clinical Significance of Indeterminate QuantiFERON-TB Gold Plus Assay Results in Hospitalized COVID-19 Patients with Severe Hyperinflammatory Syndrome
Xavier Solanich, Miguel Fernández-Huerta, Celeste Basaez, et al.
European Journal of Case Reports in Internal Medicine
|
June 7, 2024
Severe Gastrointestinal Cytomegalovirus Infection in a Patient Diagnosed with Late Onset Combined Immunodeficiency
Georgina Sauqué Pintos, Arnau Antolí Gil, Gemma Rocamora Blanch, et al.
Frontiers in Immunology
|
April 1, 2025
Non-neutralizing anti-type I interferon autoantibodies could increase thrombotic risk in critical COVID-19 patients
Mario Framil, Lydia García-Serrano, Francisco Morandeira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 7, 2023
Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial
Pierre Malchair, Jordi Giol, Vanesa García, et al.
Journal of Clinical Immunology
|
May 27, 2025
From Rare to Common: Genetic Insights into TLR7 Variants in a Multicentric Spanish Study on COVID-19 Severity
Arnau Antolí, Gardenia Vargas-Parra, Angels Sierra-Fortuny, et al.
Frontiers in Immunology
|
May 16, 2022
Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy
Arnau Antolí, Gemma Rocamora-Blanch, Mario Framil, et al.
Clinical Immunology (Orlando, Fla.)
|
April 4, 2025
Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patients
Arnau Antolí, José Luis Gómez-Vázquez, Angels Sierra-Fortuny, et al.
Frontiers in Medicine
|
July 1, 2021
Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial
Xavier Solanich, Arnau Antolí, Gemma Rocamora-Blanch, et al.
Frontiers in Immunology
|
August 9, 2021
Genetic Screening for <i>TLR7</i> Variants in Young and Previously Healthy Men With Severe COVID-19
Xavier Solanich, Gardenia Vargas-Parra, Caspar I van der Made, et al.
Page
of 2